candesartan cilexetil has been researched along with Compensatory Hyperinsulinemia in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have previously demonstrated that captopril ameliorates glucose intolerance by partially preventing the reduction in postprandial skeletal muscle blood flow." | 7.69 | Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. ( Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I, 1996) |
| "We have previously demonstrated that captopril ameliorates glucose intolerance by partially preventing the reduction in postprandial skeletal muscle blood flow." | 3.69 | Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor. ( Chen, S; Ishii, J; Kashiwabara, H; Katayama, S; Kosegawa, I, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S | 1 |
| Kashiwabara, H | 1 |
| Kosegawa, I | 1 |
| Ishii, J | 1 |
| Katayama, S | 1 |
1 other study available for candesartan cilexetil and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Bradykinin may not be involved in improvement of insulin resistance by angiotensin converting enzyme inhibitor.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensiv | 1996 |